“It’s a gift of life,” says PKD survivor Judith Belair-Kyle who received a kidney transplant on Dec. 1 from a live donor after over a year of campaigning on social media. Brittany Henriques reports. Watch her story here.
by Leigh MacMillan
Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury. The findings, reported in The Journal of Clinical Investigation, identify a novel signaling pathway as a therapeutic target in chronic kidney disease progression. Read more from the VUMC Reporter.
2022 was a breakthrough year for xenotransplantation, a procedure that could be a lifeline for patients in desperate need of a donor.
THE NIGHT BEFORE the transplant, surgeon Bartley Griffith didn’t sleep well. When he awoke around 3 am and went to make a cup of coffee, he forgot to put his mug below the machine and ended up with coffee all over the floor. Read the full story in Wired.
A multinational collaborative report of global disease trends and risk factors shows CVD remains the leading cause of death and hypertension remains the leading modifiable risk factor for premature CV death worldwide, researchers reported.
Read the full story in Healio.
Report on 1st transplant in scleroderma patient predicts future success
The case of a person with scleroderma who successfully received a lung transplant from a donor who had tested positive for COVID-19 may predict positive outcomes for other patients, according to a recent report.
“To our knowledge this represents the first successful case of lung transplantation of donor lungs positive for COVID-19,” the researchers wrote. Read more in Scleroderma News.
When 12-year-old Emma Rothman woke up in the hospital, she was surrounded by strangers using unfamiliar phrases like “medically-induced coma” and “organ donation.”
It was a Monday in 2011, and she had been in her pediatrician’s office for a diagnosis test. Read the full story on Syracuse.com.
Ultromics announced its artificial intelligence-guided device for the diagnosis of HF with preserved ejection fraction via echocardiogram has received full marketing authorization from the FDA.
The device (EchoGo Heart Failure) was developed by Ultromics, a spin-out of the University of Oxford, in collaboration with Mayo Clinic, according to a press release issued by the company.
Read the full story in Healio.
Changes in gene expression patterns in the brain associated with natural aging also were observed in the brains of those with severe COVID-19, prompting researchers to emphasize the need for neurological follow-up in recovered individuals.
Read the full story in Healio.
Study underscores effects of race, socioeconomic status on disease outcomes
People with sarcoidosis who live in neighborhoods lacking economic and social resources have lower lung function and faster lung function decline, a study in the U.S. and Canada revealed.
Non-white patients were overrepresented in the group with greater disadvantage, suggesting how race and differences in socioeconomic status can lead to poorer outcomes among people from minority backgrounds. Read more in Sarcoidosis News.
UNIVERSITY PARK, Pa. — The age, sex, and other demographic information about a patient can be used to predict whether they will need to be readmitted following a liver transplant, according to new research spearheaded by recent Penn State graduate Brittany Damazio.
Damazio led the analyses and writing on a recent publication in the Journal of Liver Transplantation as an undergraduate researcher in health policy and administration. In the paper, the researchers identified common traits among people who were readmitted to the hospital within 30 days following a liver transplant. This work could one day help doctors prevent readmissions. Read more from Penn State News.